Comments on: Nasus Pharma Announces Positive Results from a Pilot Clinical Study of FMXIN002 Intranasal Powder Epinephrine Spray in https://www.nasuspharma.com/nasus-pharma-announces-positive-results-from-a-pilot-clinical-study-of-fmxin002-intranasal-powder-epinephrine-spray-in/?utm_source=rss&utm_medium=rss&utm_campaign=nasus-pharma-announces-positive-results-from-a-pilot-clinical-study-of-fmxin002-intranasal-powder-epinephrine-spray-in New frontier in Intranasal drug delivery Tue, 07 Jun 2022 07:08:21 +0000 hourly 1 https://wordpress.org/?v=6.7